A fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management.Member of senior management. Lead the legal department of the company and its European commercial organization. Responsible for all legal aspects enabling international work plan execution. Responsible for business development activities and execution of distribution agreements for the company’s product with international partners in Central and Latin America, South East Asia and Russia as well as on-going management of the relationship with the local partner. Led and managed all legal aspects of equity rasies in NASDAQ in total amount of USD 105 million.Responsible for compliance with Israeli, U.S. and NASDAQ rules, including and complying with strict corporate governance procedures, preparing board of directors meetings and executing shareholders meetings.

A drug development company focused on innovative drugs for the treatment of central nervous system (CNS) conditions, especially for ischemic stroke and migraine.ed the legal department of the company, which was responsible for all legal aspects to enable work plan execution.Led and managed the acquisition of Thrombotech Ltd. in consideration for NIS 24 million in a stock-for-stock merge.Led and managed the cooperation and license agreements with international partners in China and South Korea for the development and registration of the company's products in these territories.Led and managed all legal aspects in two capital raise totaled in NIS 27 million.

Israel’s largest life sciences investment company. CBI is an investment and holding company focusing on pharmaceutical companies as well as medical devices companies.Responsible for the company's legal aspects, including formation and negotiation of merger and acquisition agreements, license agreements, investment agreements, loan agreements and private placements.Managed the legal aspects in a follow-on offering in TASE on 2013, which resulted in raising NIS 124 million.Managed the legal aspects in a private placement to Israeli Institutional Investor totaled in NIS 80 million.As a Company Secretary, responsible for the secretariat activities which require complying with Israeli and Tel Aviv Stock Exchange rules.

Specialized in capital markets, with an emphasis on IPOs and the full range of secondary and private offerings, representing both issuers and underwriters. Represented the underwriters syndicate in the NIS 6 Billion privatization of the Israeli Oil Refineries.Provided ongoing counsel to domestic and foreign publicly-traded companies, holding companies, private companies, NGO organizations and professional services companies.